AN2 Therapeutics ANTX
NASDAQ ANTX
$5.55 +0.23 (+4.42%)
As of: Oct 1, 2026 · 3:54 PM EDT

AN2 Therapeutics (ANTX) Preferred Stock Liabilities (2021)

Updated

AN2 Therapeutics' Preferred Stock Liabilities was $109.32 million in Q4 2021, up 1.8% from the prior quarter.

Analysis

AN2 Therapeutics (ANTX) Preferred Stock Liabilities (2021) Analysis & Trends

From Q1 2021 onward, AN2 Therapeutics has reported Preferred Stock Liabilities for 4 quarters.

  • Per Business Quant data, ANTX's Preferred Stock Liabilities in the three quarters before Q4 2021 was $107.39 million (Q3 2021), $105.47 million (Q2 2021) and $103.57 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 AN2 Therapeutics 193.16 Mn 193.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 109.32 Mn
Sep 30, 2021 107.39 Mn
Jun 30, 2021 105.47 Mn
Mar 31, 2021 103.57 Mn
API Access

AN2 Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ANTX&period=max&api_key=YOUR_API_KEY